immunity | MyInVitroAnswer.com

top of page

Autologous human tumor-immune organoid model for patient-specific prediction of response to immunotherapy

Autologous human tumor-immune organoid model for patient-specific prediction of response to immunotherapy

Autologous human tumor-immune organoid model for patient-specific prediction of response to immunotherapy

Organoid technologies

A person sketched in black and white colour holds their head, looking troubled. His thoughts are visually represented by blue lines that intersect chaotically, suggesting the person suffers from cognitive impairment related to Alzheimer's disease. Beneath his eyes, 6 abstract pattern lines of different blue shades progress toward him. These lines symbolize the 6 distinct hiPSC-derived cell lines that researchers have used to engineer a 3D immuno-glial-neurovascular human brain model for preclinical research into neurodegenerative disorders.

A person sketched in black and white colour holds their head, looking troubled. His thoughts are visually represented by blue lines that intersect chaotically, suggesting the person suffers from cognitive impairment related to Alzheimer's disease. Beneath his eyes, 6 abstract pattern lines of different blue shades progress toward him. These lines symbolize the 6 distinct hiPSC-derived cell lines that researchers have used to engineer a 3D immuno-glial-neurovascular human brain model for preclinical research into neurodegenerative disorders.

3D immuno-glial-neurovascular human brain platform for high-fidelity disease modelling

3D tissue platforms

Genoskin raises $8.7M to advance immunocompetent human skin models

Grants Awarded & Funds Raised

Parallel Bio raises $21M to expand its human immune organoid platform

Grants Awarded & Funds Raised

Qureator's preclinical tumor model featured in world's first animal-free IND approval

Qureator's preclinical tumor model featured in world's first animal-free IND approval

Qureator's preclinical tumor model featured in world's first animal-free IND approval

Clinical Trial Authorizations

bottom of page